| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |